Found: 25
Select item for more details and to access through your institution.
Personalized Nutrition as a Key Contributor to Improving Radiation Response in Breast Cancer.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 1, p. 175, doi. 10.3390/ijms23010175
- By:
- Publication type:
- Article
Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcome.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 177, n. 1, p. 77, doi. 10.1007/s10549-019-05307-8
- By:
- Publication type:
- Article
Phase II studies of methyl glyoxal bis-guanylhydrazone (NSC 32946) in carcinoma of the colon and lung.
- Published in:
- 1982
- By:
- Publication type:
- journal article
African American Patients' Psychosocial Support Needs and Barriers to Treatment: Patient Needs Assessment.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Long Term Survival after Colonic Stenting and Restenting for Malignant Colonic Obstruction.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Positive Association of Fibroadenomatoid Change with HER2-Negative Invasive Breast Cancer: A Co-Occurrence Study.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0129500
- By:
- Publication type:
- Article
Consistent Surgeon Evaluations of Three-Dimensional Rendering of PET/CT Scans of the Abdomen of a Patient with a Ductal Pancreatic Mass.
- Published in:
- PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0075237
- By:
- Publication type:
- Article
Clinical Management of EGFRI Dermatologic Toxicities: US Perspective.
- Published in:
- Oncology (08909091), 2007, v. 21, p. 17
- By:
- Publication type:
- Article
Clinical Presentation and Pathophysiology of EGFRI Dermatologic Toxicities.
- Published in:
- Oncology (08909091), 2007, v. 21, p. 4
- By:
- Publication type:
- Article
Physician Perceptions on Cancer Screening for LGBTQ+ Patients.
- Published in:
- Cancers, 2023, v. 15, n. 11, p. 3017, doi. 10.3390/cancers15113017
- By:
- Publication type:
- Article
Disparities in care of older adults of color with cancer: A narrative review.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 3, p. 1, doi. 10.1002/cam4.6790
- By:
- Publication type:
- Article
Sudden-onset thrombocytopenia with oxaliplatin.
- Published in:
- 2003
- By:
- Publication type:
- Case Study
Differences in Breast Carcinoma Characteristics in Newly Diagnosed African-American and Caucasian Patients.
- Published in:
- Cancer (0008543X), 2007, v. 110, n. 4, p. 876, doi. 10.1002/cncr.22836
- By:
- Publication type:
- Article
"I need more knowledge": Qualitative analysis of oncology providers' experiences with sexual and gender minority patients.
- Published in:
- Frontiers in Psychology, 2022, v. 13, p. 1, doi. 10.3389/fpsyg.2022.763348
- By:
- Publication type:
- Article
Targeted Therapy for Metastatic Colorectal Cancer: Role of Aflibercept.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 2, p. 73, doi. 10.1016/j.clcc.2012.08.001
- By:
- Publication type:
- Article
The efficacy and safety of panitumumab administered concomitantly with FOLFIRI or Irinotecan in second-line therapy for metastatic colorectal cancer: the secondary analysis from STEPP (Skin Toxicity Evaluation Protocol With Panitumumab) by KRAS status.
- Published in:
- 2011
- By:
- Publication type:
- journal article
5-Fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) plus sunitinib or bevacizumab as first-line treatment for metastatic colorectal cancer: a randomized Phase IIb study.
- Published in:
- Cancer Management & Research, 2015, v. 7, p. 165, doi. 10.2147/CMAR.S61408
- By:
- Publication type:
- Article
Impact of ethnicity on the outcome of men with metastatic, hormone-sensitive prostate cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Clinical presentations and outcomes in pulmonary embolism patients with cancer.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2021, v. 51, n. 2, p. 430, doi. 10.1007/s11239-020-02298-y
- By:
- Publication type:
- Article
Paclitaxel With or Without Cixutumumab as Second-Line Treatment of Metastatic Esophageal or Gastroesophageal Junction Cancer: A Randomized Phase II ECOG-ACRIN Trial.
- Published in:
- Oncologist, 2023, v. 28, n. 9, p. 827, doi. 10.1093/oncolo/oyad096
- By:
- Publication type:
- Article
Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5‐Fluorouracil, and Leucovorin Versus Oxaliplatin, 5‐Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG‐ACRIN Research Group (E5204)
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. e798, doi. 10.1634/theoncologist.2019-0437
- By:
- Publication type:
- Article
A Randomized, Phase II Trial of Standard Triweekly Compared with Dose-Dense Biweekly Capecitabine Plus Oxaliplatin Plus Bevacizumab as First-Line Treatment for Metastatic Colorectal Cancer: XELOX-A-DVS (Dense Versus Standard)
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
A Randomized, Phase II Trial of Standard Triweekly Compared with Dose-Dense Biweekly Capecitabine Plus Oxaliplatin Plus Bevacizumab as First-Line Treatment for Metastatic Colorectal Cancer: XELOX-A-DVS (Dense Versus Standard).
- Published in:
- Oncologist, 2012, v. 17, n. 7, p. 937, doi. 10.1634/theoncologist.2012-0071
- By:
- Publication type:
- Article
Combining antivascular endothelial growth factor and anti-epidermal growth factor receptor antibodies: randomized phase II study of irinotecan and cetuximab with/without ramucirumab in second-line colorectal cancer (ECOG-ACRIN E7208).
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 9, p. 1487, doi. 10.1093/jnci/djae114
- By:
- Publication type:
- Article
The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design.
- Published in:
- 2020
- By:
- Publication type:
- journal article